Old Web
English
Sign In
Acemap
>
authorDetail
>
Rachel E. Burdon
Rachel E. Burdon
Oregon Health & Science University
Medicine
Clinical trial
Cancer
Intensive care medicine
Institutional review board
3
Papers
133
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Quality of reporting of serious adverse drug events to an institutional review board: A case study with the novel cancer agent, imatinib mesylate
2009
Clinical Cancer Research
David A. Dorr
Rachel E. Burdon
Dennis P. West
J. Lagman
C. H. Georgopoulos
Steven M. Belknap
June M. McKoy
Benjamin Djulbegovic
Beatrice J. Edwards
Sigmund A. Weitzman
Simone N Boyle
Martin S. Tallman
Moshe Talpaz
Oliver Sartor
Charles L. Bennett
Show All
Source
Cite
Save
Citations (24)
The Effect of Technology-Supported, Multidisease Care Management on the Mortality and Hospitalization of Seniors
2008
Journal of the American Geriatrics Society
David A. Dorr
Adam B. Wilcox
Cherie P. Brunker
Rachel E. Burdon
Steven M. Donnelly
Show All
Source
Cite
Save
Citations (109)
New IRB guidelines: Will cancer patient safety improve?
2007
Journal of Clinical Oncology
Cara Angelotta
David A. Dorr
Dennis P. West
Rachel E. Burdon
J. Lagman
D. Workman
John F. Hurdle
Steven M. Belknap
Charles L. Bennett
Show All
Source
Cite
Save
Citations (0)
1